Search Results - "Acelajado, M. Czarina"

Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists' recommendations for active treatment or active surveillance: a randomized clinical utility trial by Peabody, John W, DeMaria, Lisa M, Tamondong-Lachica, Diana, Florentino, Jhiedon, Czarina Acelajado, M, Ouenes, Othman, Richie, Jerome P, Burgon, Trever

“…Of the more than 1.1 million men diagnosed worldwide annually with prostate cancer, the majority have indolent tumors. Distinguishing between aggressive and…”
Get full text

Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results by Peabody, John, Schrecker, Joshua, Heltsley, Rebecca, Paculdo, David, de Belen, Enrico, Tamondong-Lachica, Diana, Acelajado, M. Czarina, Ouenes, Othman, Kennedy, Trina, Jeter, Elaine

“…Drug–drug interactions (DDIs) are a serious problem in the healthcare system, leading to excess healthcare utilization and costs. We conducted a second…”
Get full text

Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners by Peabody, John, Paculdo, David, Acelajado, M. Czarina, Burgon, Trever, Dahlen, Jeffrey R.

“…HbA1c is widely used as the standard measure to track glycemic control in patients with diabetes and pre-diabetes but measures average levels of glycated…”
Get full text

Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists by Valdenor, Czarlota, McCullough, Peter A., Paculdo, David, Acelajado, M. Czarina, Dahlen, Jeffrey R., Noiri, Eisei, Sugaya, Takeshi, Peabody, John

“…Contrast-induced acute kidney injury (CI-AKI) occurs in up to 10% of cardiac catheterizations and coronary interventions, resulting in increased morbidity,…”
Get full text

Reducing Unneeded Clinical Variation in Sepsis and Heart Failure Care to Improve Outcomes and Reduce Cost: A Collaborative Engagement with Hospitalists in a MultiState System by Yurso, Michael, Box, Brent, Burgon, Trever, Hauck, Loran, Tagg, Krystyna, Clem, Kathleen, Paculdo, David, Acelajado, M Czarina, Tamondong‐Lachica, Diana, Peabody, John W

“…OBJECTIVE To (1) measure hospitalist care for sepsis and heart failure patients using online simulated patients, (2) improve quality and reduce cost through…”
Get full text

Treatment of resistant hypertension by Czarina Acelajado, M, Calhoun, D A

“…Resistant hypertension (RH) is a common clinical problem. Patients with RH have increased cardiovascular risk. These patients also have high risk for having…”
Get more information

Resistant Hypertension, Secondary Hypertension, and Hypertensive Crises: Diagnostic Evaluation and Treatment by Acelajado, Maria Czarina, MD, Calhoun, David A., MD

“…Hypertension is a very common modifiable risk factor for cardiovascular morbidity and mortality. Patients with hypertension represent a diverse group. In…”
Get full text

Hypertension in the Elderly by Acelajado, Maria Czarina, MD, Oparil, Suzanne, MD

“…Hypertension is an important risk factor for cardiovascular morbidity and mortality, particularly in the elderly. Blood pressure elevation in the elderly is…”
Get full text

Low Rates of Genetic Testing in Children With Developmental Delays, Intellectual Disability, and Autism Spectrum Disorders by Peabody, John, DeMaria, Lisa, Tamandong-LaChica, Diana, Florentino, Jhiedon, Acelajado, Maria Czarina, Burgon, Trever

“…To explore the routine and effective use of genetic testing for patients with intellectual disability and developmental delay (ID/DD), we conducted a…”
Get full text

Both morning and evening dosing of nebivolol reduces trough mean blood pressure surge in hypertensive patients by Acelajado, Maria Czarina, Pisoni, Roberto, Dudenbostel, Tanja, Oparil, Suzanne, Calhoun, David A, Glasser, Stephen P

“…The morning blood pressure surge (MBPS) has been shown to be an independent predictor of cardiovascular events. There is insufficient evidence on the effect of…”
Get more information